India Medical Device Exports: 5 High-Growth Markets, $4.9B Deficit

For logistics and supply chain planners, the actionable signal in this India Exim Bank study is not simply 'export more' — it is a market-routing map. The report isolates five import markets growing faster than the global average where Indian medical device exporters hold only a modest share, meaning the next freight, warehousing, and compliance investment should be sequenced around Mexico, Brazil, the UK, Poland, and Canada rather than saturated legacy corridors.

India Exim Bank, the state-owned institution that finances and promotes India's international trade, has released a study that functions as a market-routing map for one of the country's most strategically sensitive import categories. According to the report, Mexico, Brazil, the United Kingdom, Poland, and Canada have emerged as the top five high-growth import markets for medical equipment — yet India's export share in each remains modest. The study screened markets where medical device imports grew above the global average during 2022-2024 and where each country held at least a 1 percent share of global imports in the relevant product category, making the resulting list a data-driven shortlist rather than a generic export wish list.

“

According to the report, Mexico, Brazil, the United Kingdom, Poland, and Canada have emerged as the top five high-growth import markets for medical equipment — yet India's export share in each remains modest.

The category-level breakdown is where the study earns its practical value, because the priority geographies shift substantially by product line. For medical equipment overall, the high-growth markets are Mexico, Brazil, the UK, Poland, and Canada. For orthopaedic equipment, the list changes to Mexico, Ireland, Poland, Russia, and the United States — a striking mix that pairs emerging markets with two of the world's most demanding regulatory regimes. Personal protective equipment demand is concentrated in Hungary, Turkey, Vietnam, Hong Kong, and Mexico, while consumables and disposables show the strongest growth in Australia, the UK, Saudi Arabia, Italy, and Singapore. For exporters and their logistics partners, this means a disposables manufacturer should be building compliance files and distribution relationships in Riyadh, Singapore, and Sydney, while an orthopaedics maker should be studying Mexico City, Dublin, and Warsaw corridors. A single consolidated export strategy would misallocate both trade-promotion capital and freight investment.

The strategic backdrop is India's entrenched import dependence. The study notes that India's medical devices trade deficit stood at USD 4.9 billion in 2024, confirming that the country remains a net buyer of medical technology even as it attempts to grow as an exporter. That deficit is the pressure that makes export diversification a policy priority rather than an optional growth theme: closing the gap requires not just selling more abroad but reducing the domestic reliance on imported devices in the very categories being targeted. The report's own framing — that the gap between rising import requirements in these markets and India's limited presence "offers potential to expand" — is deliberately measured, signaling headroom rather than guaranteed share gains.